These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18307745)

  • 1. Reactive oxygen species and glucocorticoid-induced hypertension.
    Ong SL; Zhang Y; Whitworth JA
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):477-82. PubMed ID: 18307745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
    Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular sources of reactive oxygen species in hypertension.
    Puddu P; Puddu GM; Cravero E; Rosati M; Muscari A
    Blood Press; 2008; 17(2):70-7. PubMed ID: 18568695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertension.
    Mitchell BM; Cook LG; Danchuk S; Puschett JB
    Am J Hypertens; 2007 Dec; 20(12):1297-304. PubMed ID: 18047920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidase and uncoupled nitric oxide synthase are major sources of reactive oxygen species in oral squamous cell carcinoma. Potential implications for immune regulation in high oxidative stress conditions.
    Czesnikiewicz-Guzik M; Lorkowska B; Zapala J; Czajka M; Szuta M; Loster B; Guzik TJ; Korbut R
    J Physiol Pharmacol; 2008 Mar; 59(1):139-52. PubMed ID: 18441394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and vascular remodelling.
    Fortuño A; San José G; Moreno MU; Díez J; Zalba G
    Exp Physiol; 2005 Jul; 90(4):457-62. PubMed ID: 15890797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
    Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
    Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease.
    Szasz T; Thakali K; Fink GD; Watts SW
    Exp Biol Med (Maywood); 2007 Jan; 232(1):27-37. PubMed ID: 17202583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
    Guzik TJ; Harrison DG
    Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting sources of superoxide and increasing nitric oxide bioavailability in hypertension.
    Elmarakby AA; Williams JM; Pollock DM
    Curr Opin Investig Drugs; 2003 Mar; 4(3):282-90. PubMed ID: 12735229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species and endothelial function in diabetes.
    Fatehi-Hassanabad Z; Chan CB; Furman BL
    Eur J Pharmacol; 2010 Jun; 636(1-3):8-17. PubMed ID: 20371238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressing NADPH oxidase-dependent oxidative stress in the vasculature with nitric oxide donors.
    Selemidis S
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1395-401. PubMed ID: 18954334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nox2-containing NADPH oxidase deficiency confers protection from hindlimb ischemia in conditions of increased oxidative stress.
    Haddad P; Dussault S; Groleau J; Turgeon J; Michaud SE; Ménard C; Perez G; Maingrette F; Rivard A
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1522-8. PubMed ID: 19574557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species in hypertension; An update.
    Lassègue B; Griendling KK
    Am J Hypertens; 2004 Sep; 17(9):852-60. PubMed ID: 15363831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
    Wood KC; Granger DN
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.
    Förstermann U
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):338-49. PubMed ID: 18461048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.
    Montezano AC; Touyz RM
    Ann Med; 2012 Jun; 44 Suppl 1():S2-16. PubMed ID: 22713144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells.
    Tumur Z; Niwa T
    Am J Nephrol; 2009; 29(6):551-7. PubMed ID: 19129694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.